Deep Brain Reorienting (DBR) in Post-traumatic Stress Disorder (PTSD)
Key facts
- Who runs it
- The Royal Ottawa Mental Health Centre
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Starts
- Dec 2026
- Expected to end
- Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Deep Brain Reorienting (DBR)
- Treatment-as-usual (TAU)
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- 18-65 years old
- Fluent English speaker
- Resident of Ontario, Canada (for psychology licensing purposes)
- Comfortable using electronic devices (i.e., laptop, tablet, smartphone, etc.)
- Meet criteria for a primary diagnosis of PTSD via the DSM-5 on the Clinician Administered PTSD Scale (CAPS-5). Given high rates of PTSD co-morbidity with major depressive disorder and anxiety disorders, these participants will not be excluded from the study, allowing for a naturalistic sample
- Currently being followed by a family physician or psychiatrist
- Able to provide written informed consent
Who cannot take part
- Individuals receiving trauma-based therapy or trauma-focused therapy (e.g., CBT, trauma exposure therapy, EMDR) in the 4 weeks preceding study referral (or from screening to initial assessment interview)
- History of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score < 15 at the time of incident assessed retrospectively by participant)
- Serious illness (including cardiac, hepatic, renal, respiratory, endocrinologic, neurologic, or hematologic disease) that is not stabilized based on the judgment of primary investigator
- Major untreated medical illness (e.g., cancer, thyroid disorder)
- Any other condition that might interfere with the person's capacity to give informed consent, or to adhere to the study protocol; Psychological/Psychiatric
- Current or past psychotic spectrum disorders, bipolar disorders or psychosis, obsessive-compulsive disorder, schizophrenia will be excluded
- Participants will also be excluded for active suicidality, history of pervasive developmental disorders, or any other major medical illnesses
- Meeting criteria for substance use disorder in the past three months on the MINI
- Any other condition that might interfere with the person's capacity to give informed consent, or to adhere to the study protocol; Legal Status
- Medical
- Chronic opioid analgesic use within the last three months
- May not benefit from short-term treatment (e.g., as a result of situational factors, volatile life circumstances), as determined by study assessment
- Currently involved in trauma-related litigation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to determine the effects of a clinical treatment called deep brain reorienting (DBR) on post-traumatic stress disorder (PTSD).
Read full original descriptionShow less
We will be investigating if DBR helps reduce PTSD symptoms. To do so, we will be assigning participants to either receive DBR or continue with their current treatment. By comparing the results from the two groups, we will learn if DBR could be an effective treatment for PTSD.
Participants will be randomly assigned (e.g., like the flip of a coin) to receive either eight weekly sessions of DBR treatment or continue with their current treatment. Participants assigned to continue with their current treatment will be offered eight DBR sessions after they have completed the study.
The study will take place online/virtually over video conferencing.
The 2 groups in the trial
- Deep Brain Reorienting (DBR)Treatment being tested
Participants randomly assigned to the DBR group will be asked to attend eight, 50-minute, one-on-one sessions of DBR with a therapist.
- Treatment-as-usual (TAU)Existing treatment, for comparison
Participants randomly assigned to the TAU group will continue to receive the ongoing conventional treatment that they are currently being provided for 8 weeks (the equivalent time for 8 sessions of DBR in the treatment group).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Deep Brain Reorienting on Post-traumatic Stress Disorder
- Criteria questions
- Built from NCT07939178, who can take part
- Record updated
- 16 November 2026